This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hyloris Developments Sa. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Mohammad Alkhalili in Dental Care
Introduction
Mohammad Alkhalili is an innovative inventor based in North Richland Hills, TX (US). He has made significant contributions to the field of dental care through his patented inventions. His work focuses on improving patient outcomes during dental procedures, particularly for those with bleeding disorders.
Latest Patents
Alkhalili holds a patent for a tranexamic acid oral solution. This invention provides methods and compositions for treating patients with bleeding disorders during or after dental procedures. The solution aims to reduce bleeding and the need for factor replacement therapy. The aqueous pharmaceutical compositions include tranexamic acid, sodium carboxymethyl cellulose, Tween® 20, and menthol. Notably, this composition exhibits good long-term stability, minimal discoloration over time, and reduced bitterness compared to a control solution of tranexamic acid and water. He has 1 patent to his name.
Career Highlights
Alkhalili's career is marked by his dedication to advancing dental care through innovative solutions. His work at Hyloris Developments SA has allowed him to focus on developing effective treatments that enhance patient safety and comfort during dental procedures.
Collaborations
Some of his notable coworkers include Mary Beth G. Erstad and Thomas Gerner Jacobsen. Their collaboration has contributed to the success of his projects and the development of new solutions in the field.
Conclusion
Mohammad Alkhalili's contributions to dental care through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to influence the field and offers promising solutions for those with bleeding disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile